Posts Tagged ‘non-STEMI’

February 23rd, 2015

Selections from Richard Lehman’s Literature Review: February 23rd

This week’s topics include a comparison of fondaparinux and low-molecular-weight heparin in patients with non-STEMI and a study of multiple BP medications, achieved BP, and mortality in older nursing home residents.

November 3rd, 2014

Selections from Richard Lehman’s Literature Review: November 3rd

This week’s topics include dual-antiplatelet treatment beyond one year after DES implantation, reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome, and more.

September 1st, 2013

Inside the ACCOAST Trial of Pretreatment Prasugrel

, , and

Gilles Montalescot, lead investigator of the ACCOAST trial, discusses why prasugrel pretreatment did not benefit patients with non–ST-segment elevation acute coronary syndromes.

November 8th, 2010

Non-STEMI Patients Delay Seeking Help Just As Long as STEMI Patients

Non-STEMI patients delayed going to the hospital for as long in 2006 as they did in 2001, according to a report published in the Archives of Internal Medicine. Henry Ting and colleagues analyzed data from 104,622 non-STEMI patients enrolled in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of […]

August 9th, 2010

Prior Medication Use Shifts Balance of MIs

Patients who present with MI and are taking aspirin, beta-blockers, ACE inhibitors, or statins are more likely to have a non-STEMI than a STEMI, according to findings from a large Swedish registry published in the Archives of Internal Medicine. Lena Björck and colleagues analyzed data from over 100,000 consecutive admissions for MI. Some 61% of STEMI […]